Evidence map›Paper›PMID 25107308›Full record

ArticleMicrobiology (Reading, England)2014

Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate demethylation and impact environmental stress adaptation in Aspergillus fumigatus.

Sara J Blosser, Brittney Merriman, Nora Grahl, Dawoon Chung, Robert A Cramer

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Directed evolution of the pathogenic moldAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Molecular Characterization of Sterol C4-Methyl Oxidase inInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Isobavachalcone exhibits antifungal and antibiofilm effects againstFrontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Novel Insights intoJournal of fungi (Basel, Switzerland) · 2022
    Review
  14. Deciphering Molecular Determinants UnderlyingInternational journal of molecular sciences · 2022
    Article
  15. Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Review
  16. Long Terminal Repeat RetrotransposonAntimicrobial agents and chemotherapy · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sara J BlosserDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Brittney MerrimanDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Nora GrahlDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Dawoon ChungDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Robert A CramerDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Montana State University · US

Funding

SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONSP20RR024237 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI SINGEL, DAVID J · 2008 to 2011
$8.1M
Center for Zoonotic and Emerging Infectious DiseasesP20GM103500 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2012 to 2013
$4.2M
Hypoxia Adaptation and Fungal Virulence of Aspergillus fumigatusR01AI081838 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI CRAMER, ROBERT ANDREW · 2009 to 2017
$2.9M
NCRR NIH HHS P20 RR024237NIAID NIH HHS R01 AI081838NIAID NIH HHS R01AI81838NIGMS NIH HHS GM103500NIGMS NIH HHS P20 GM103500
6 · The paper itself

Abstract

The human pathogen Aspergillus fumigatus adapts to stress encountered in the mammalian host as part of its ability to cause disease. The transcription factor SrbA plays a significant role in this process by regulating genes involved in hypoxia and low-iron adaptation, antifungal drug responses and virulence. SrbA is a direct transcriptional regulator of genes encoding key enzymes in the ergosterol biosynthesis pathway, including erg25A and erg25B, and ΔsrbA accumulates C4-methyl sterols, suggesting a loss of Erg25 activity [C4-sterol methyl oxidase (SMO)]. Characterization of the two genes encoding SMOs in Aspergillus fumigatus revealed that both serve as functional C4-demethylases, with Erg25A serving in a primary role, as Δerg25A accumulates more C4-methyl sterol intermediates than Δerg25B. Single deletion of these SMOs revealed alterations in canonical ergosterol biosynthesis, indicating that ergosterol may be produced in an alternative fashion in the absence of SMO activity. A Δerg25A strain displayed moderate susceptibility to hypoxia and the endoplasmic reticulum stress-inducing agent DTT, but was not required for virulence in murine or insect models of invasive aspergillosis. Inducing expression of erg25A partially restored the hypoxia growth defect of ΔsrbA. These findings implicated Aspergillus fumigatus SMOs in the maintenance of canonical ergosterol biosynthesis and indicated an overall involvement in the fungal stress response.

Indexed as

Adaptation, PhysiologicalAspergillosisAspergillus fumigatusErgosterolFungal ProteinsHumansMethylationMixed Function OxygenasesErgosterolFungal Proteinsmethylsterol monooxygenaseMixed Function Oxygenases

Identifiers

PMID25107308
PMCPMC4219106
OpenAlexW2146720199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.